resveratrol has been researched along with 4-aminobenzoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chin, T; Fronczek, FR; Galbreath, M; Iimoto, DS; Isovitsch, R; Jackson, W; Lee, D; Perez, P | 1 |
| Bhat, HK; Bhat, NK; Chatterjee, A; Dandawate, P; Murphy, L; Padhye, S; Ronghe, A; Singh, B | 1 |
| Li, W; Lu, T; Sun, CC; Sun, WJ; Tong, HHY; Zheng, Y; Zhou, Z | 1 |
3 other study(ies) available for resveratrol and 4-aminobenzoic acid
| Article | Year |
|---|---|
Aryl morpholino triazenes inhibit cytochrome P450 1A1 and 1B1.
Topics: Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Morpholinos; Structure-Activity Relationship; Triazenes | 2016 |
Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.
Topics: Antineoplastic Agents; Catechols; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Estrogen Receptor alpha; Estrogen Receptor beta; Humans; Molecular Docking Simulation; para-Aminobenzoates; Proto-Oncogene Proteins c-myc; Resveratrol; RNA, Messenger; Schiff Bases; Stilbenes | 2014 |
Resveratrol cocrystals with enhanced solubility and tabletability.
Topics: Benzamides; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallization; Magnetic Resonance Spectroscopy; Models, Molecular; para-Aminobenzoates; Powder Diffraction; Resveratrol; Solubility; Spectroscopy, Fourier Transform Infrared; Stilbenes; Tablets; Temperature; X-Ray Diffraction | 2016 |